Why the Nufarm (ASX:NUF) share price climbed higher today

The company's shares are jumping higher on the latest news.

| More on:
Hands grabbing for high rung on a ladder pointing to the sky

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Nufarm Ltd (ASX: NUF) share price climbed higher today following a positive announcement from the company during afternoon trade.

At market close, the agricultural chemicals company's shares finished up 3.33% high, trading at $4.51.

What did Nufarm announce?

Investors are buying up Nufarm shares in hopes that the company's latest news will see penetration into new markets.

According to its release, Nufarm advised that the United States Food and Drug Administration (FDA) has approved its Nutriterra Omega-3 Canola Oil as a new dietary ingredient.

Developed by Nuseed, a wholly-owned subsidiary of Nufarm, the Canola-based Omega-3 canola oil is the world's first plant-based source of DHA and EPA long-chain omega-3 fatty acids.

Its Omega-3 profile can be used to support human nutrition (marketed as Nutriterra) and fish feed (marketed as Aquaterra).

A human clinical trial previously conducted by Nuseed recorded significantly improved omega-3 levels leading to reduced cardiovascular and cognitive risks. The dietary supplements quickly absorbed the oil's long-chain omega-3, which were merged into blood lipids.

Nufarm also believes its Aquaterra product can reduce pressure on fisheries to catch wild-fish stocks.

The company has obtained human food and fish feed approvals in Australia, New Zealand, and Canada. Additional regulatory applications in other key markets around the world are progressing.

Management commentary

Nufarm CEO, Greg Hunt commented:

The FDA's acknowledgment along with our recently completed human clinical trial, allows us to progress our plans to expand into the human nutrition market and meet a growing demand for plant-based omega-3 essential oil options.

Mr Hunt went on to add:

With FDA recognition of Nuseed's conclusion that Nutriterra is a safe new dietary ingredient, we are well placed to secure commercial partnerships that will attract new consumers, enter into new segments and raise consumption of omega-3.

About the Nufarm share price

Over the last 12 months, Nufarm shares have gained a little over 5%, with year-to-date up around 10%. The company's share price reached a 52-week high of $5.60 in April, before treading lower.

Nufarm has a market capitalisation of roughly $1.7 billion, with approximately 379 million shares on its books.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

A happy young couple lie on a wooden deck using a skateboard for a pillow.
Share Gainers

These were the best-performing ASX 200 shares in March

These shares made their shareholders smile in March thanks to some very big gains.

Read more »

Businessman using a digital tablet with a graphical chart, symbolising the stock market.
Opinions

2 ASX shares I have been buying in 2024!

I’m a believer in the long-term outlook of these stocks.

Read more »

Stock market chart in green with a rising arrow symbolising a rising share price.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a massive day for the ASX 200, with a new all-time high recorded.

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Technology Shares

This ASX tech stock rocketed 60% in March! Can it keep on delivering?

After soaring in March, the ASX tech stock is now up 169% since this time last year.

Read more »

Broker Notes

Brokers name 3 ASX shares to buy now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A young man clasps his hand to his head with his eyes closed and a pained expression on his face as he clasps a laptop computer in front of him, seemingly learning of bad news or a poor investment.
Share Fallers

Why Burgundy Diamond Mines, Clarity Pharmaceuticals, EML, and Zip are sinking today

These ASX shares are ending the week in the red. But why?

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Mesoblast, Newmont, Pilbara Minerals, and Platinum shares are jumping

These ASX shares are ending the week strongly. But why?

Read more »

a young boy dressed up in a business suit and tie has a cute grin and holds two fingers up.
Opinions

2 of my top ASX 200 shares to consider buying before April

I would happily exchange dollars for these two shares right now.

Read more »